Gennex Laboratories Ltd Nine Monthly Results

Gross Sales

97.58

53.21

46.95

41.04

43.44

Excise Duty

0

0

0

0

0

Net Sales

97.58

53.21

46.95

41.04

43.44

Other Operating Income

6.6

2.89

1.81

0.34

0.5

Other Income

0

0

0

0

0

Total Income

104.17

56.1

48.76

41.37

43.94

Total Expenditure

82.87

40.43

43.64

36.44

39.46

PBIDT

21.3

15.67

5.12

4.94

4.48

Interest

2.41

2.34

0.55

0.54

0.53

PBDT

18.89

13.33

4.58

4.4

3.95

Depreciation

1.45

2.14

0.72

0.59

0.66

Minority Interest Before NP

0

0

0

0

0

Tax

2.35

2.51

0.97

0.96

0.83

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

15.1

8.68

2.88

2.85

2.46

Minority Interest After NP

1.25

0.51

0

0

0

Net Profit after Minority Interest

13.84

8.17

2.88

2.85

2.46

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

13.84

8.17

2.88

2.85

2.46

EPS (Unit Curr.)

0.66

0.49

0.18

0.23

0.19

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

22.74

17.74

16.11

12.65

12.65

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

21.82

29.44

10.9

12.03

10.31

PBDTM(%)

19.35

25.05

9.75

10.72

9.09

PATM(%)

15.47

16.31

6.13

6.94

5.66